ADRs End Slightly Higher; BT Group, Randgold and Novartis Trade Actively
May 10 2018 - 7:17PM
Dow Jones News
International stocks trading in New York closed slightly higher
Thursday.
The BNY Mellon index of American depositary receipts rose 0.5%
to 154.43. The European index decreased 0.01% to 141.93. The Asian
index gained 0.9% to 184.38. The Latin American index rose 2.9% to
259.13. And the emerging-markets index increased 1.5% to
337.67.
BT Group PLC (BT), Randgold Resources Ltd. (GOLD) and Novartis
AG (NVS) were among those with ADRs that traded actively.
BT Group said Thursday it will cut 13,000 jobs over the next
three years and will hire around 6,000 new employees to support
network deployment and customer service. The British
telecommunications and TV provider also will exit its central
London headquarters to focus on 30 strategic sites. BT expects to
deliver cost-savings of GBP1.5 billion. In the fourth quarter, the
telecoms company made a pretax profit of GBP872 million compared
with GBP440 million in the year-earlier period. Analysts forecast a
pretax profit of GBP887 million. Quarterly revenue declined 2.5% to
GBP5.97 billion from GBP6.12 billion a year earlier. Analysts
expected revenue of GBP6.06 billion. For fiscal 2019, BT forecasts
underlying revenue will fall 2% and adjusted Ebitda will be between
GBP7.3 billion and GBP7.4 billion. ADRs of BT Group fell 9.6% to
$14.70.
Randgold reported a 27% drop in first-quarter pretax profit due
to decreased gold sales and higher production costs. The
Africa-focused gold miner is keeping its 2018 production guidance
for 2018 at 1.3 million to 1.35 million ounces of gold production
that, after the expected weaker first quarter, implies it will need
to average quarterly gold output of about 340,000 ounces for the
rest of the year, notes SP Angel. ADRS of Randgold fell 4.5% to
$78.61.
Novartis Chief Executive Vasant Narasimhan said the company
"made a mistake" agreeing to pay Trump lawyer Michael Cohen $1.2
million for what Novartis has described as his insight into
health-care policy. In an email to the Swiss drug company's
employees on Thursday reviewed by The Wall Street Journal, Dr.
Narasimhan said he felt "frustrated" by the arrangement, which was
struck under a previous chief executive. Dr. Narasimhan, who joined
the company in 2005, became chief executive in February. Novartis
disclosed earlier this week that it paid Mr. Cohen's company
Essential Consultants LLC $100,000 a month under the one-year
contract, which ended in February. The private company was the same
one Mr. Cohen used to direct $130,000 in October 2016 to a former
adult-film actress, who goes by the name Stormy Daniels, to prevent
her from discussing an alleged sexual encounter with Mr. Trump.
Messrs. Trump and Cohen deny the encounter took place. ADRs of
Novartis fell 0.2% to $76.94.
Write to copydesk@dowjones.com
(END) Dow Jones Newswires
May 10, 2018 20:02 ET (00:02 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Randgold Resources Limited ADS Each Represented BY One Ordinary Share (delisted) (NASDAQ:GOLD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Randgold Resources Limited ADS Each Represented BY One Ordinary Share (delisted) (NASDAQ:GOLD)
Historical Stock Chart
From Nov 2023 to Nov 2024